Netherlands stocks higher at close of trade; AEX up 1.13%

The article is broadly risk-on, with Nvidia reportedly rising after news that the U.S. cleared Chinese firms to buy H200 chips, a positive signal for AI-related demand and export access. Separately, the AEX rose 1.13%, with ABN AMRO, BESI, and ASML all hitting all-time highs and advancing 3.01% to 3.53%. Commodities were softer, with crude down 0.33% to $100.69, Brent down 0.88% to $104.70, and gold down 0.54% to $4,681.40, while the AEX Volatility index was unchanged at 21.09.

Analysis

The market is treating this as a clean win for the AI supply chain, but the more interesting signal is that export-control optionality is now being repriced as a revenue bridge rather than a terminal restriction. That matters for NVDA because constrained China access was one of the few credible bear arguments left; if even a limited reopening is tolerated, near-term EPS revisions can improve without needing a fresh demand cycle. The second-order effect is that the strongest relative beneficiaries may be the names with the most leveraged operating margins and the least China sensitivity on the rest of their mix, which supports ASML more than the broader semiconductor complex.

ASML’s move is less about direct H200 exposure and more about sentiment spillover: when investors believe the AI capex cycle is still structurally intact, lithography and advanced packaging names regain multiple support. The risk is that this is a policy headline, not a regime change; if the license framework is narrow or reversible, the trade can fade quickly over days to weeks. A bigger medium-term risk is that the market overestimates the durability of China demand while underestimating how quickly domestic substitution and geopolitical tightening can cap actual unit volumes.

The contrarian read is that the initial squeeze may be bigger than the fundamental delta. If China access expands only modestly, the revenue benefit to NVDA is likely smaller than the current implied rerating, while the real beneficiaries could be equipment and packaging suppliers via improved sentiment and order visibility. That creates a setup where the first move is in the headline-sensitive megacap, but the better risk/reward is in cleaner AI enablers with less policy overhang.

Watch for whether semis outperform the Nasdaq on the next 3-5 sessions; if they do not, this was likely a positioning event rather than a durable revision cycle. The key reversal trigger is any clarification that the H200 allowance is administrative, temporary, or conditioned on chip-level constraints that limit export volumes.

Key Decisions for Investors

• Long ASML vs short NVDA for 2-4 weeks: ASML should capture the cleaner multiple expansion from AI capex optimism, while NVDA carries the most policy reversal risk; target 1.5-2.0x relative return if sentiment broadens but export rules remain murky.
• Buy NVDA on a pullback only, using 1-2 week downside puts or a call spread instead of outright stock: headline-driven upside is plausible, but the asymmetry favors waiting for confirmation that this is a durable licensing change.
• Add to SMCI only on confirmation of semiconductor breadth, not on the initial headline: if AI infrastructure names keep outperforming for 3+ sessions, the stock can re-rate sharply; if not, avoid chasing because it is most exposed to positioning unwind.
• If holding semis, hedge with short-term QQQ puts or a Nasdaq call spread overwrite: the policy catalyst is idiosyncratic and can fail to lift the broader index, so pay for protection over the next 1-2 weeks.
• For tactical traders, fade the first intraday spike in NVDA if volume decays: use a tight stop above the high and target a retracement to the pre-news VWAP over 2-5 sessions if no follow-through emerges.